BridgeBio Pharma (BBIO) Revenue (2020 - 2026)
BridgeBio Pharma (BBIO) posted Revenue of $243.68 million for Q2 2026, up 120.4% from $110.57 million a year earlier and up 25.3% from the prior quarter.
BridgeBio Pharma (BBIO) Revenue (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at BridgeBio Pharma was $713.07 million, up 202.4% year-over-year; for FY2025, it was $502.08 million, up 126.3% from FY2024.
- Annual Revenue shows a five-year compound annual growth rate of 127.4% (FY2020 to FY2025).
- In prior years, BridgeBio Pharma's Revenue was $221.9 million in FY2024, $9.3 million in FY2023 (-88.0%), $77.65 million in FY2022 (+11.4%) and $69.72 million in FY2021 (+745.1%).
- The Q2 2026 figure stands as the highest quarterly Revenue in data going back to Q3 2019.
- On a year-over-year basis, Revenue increased in three of the last five quarters, with growth averaging 69.3%.
- The strongest year-over-year quarter for Revenue in the past five years was Q1 2022, with growth of 266.7%; the weakest was Q2 2023, with a decline of 97.8%.
- According to Business Quant data, Revenue for the three prior quarters was $194.52 million (Q1 2026), $154.18 million (Q4 2025) and $120.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | BridgeBio Pharma | 13.01 Bn | 10.12 Bn | 228.63 Mn | 243.68 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 243.68 Mn |
| Mar 31, 2026 | 194.52 Mn |
| Dec 31, 2025 | 154.18 Mn |
| Sep 30, 2025 | 120.70 Mn |
| Jun 30, 2025 | 110.57 Mn |
| Mar 31, 2025 | 116.63 Mn |
| Dec 31, 2024 | 5.88 Mn |
| Sep 30, 2024 | 2.73 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Mar 31, 2024 | 211.12 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 4.09 Mn |
| Jun 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 338,000.00 |
| Jun 30, 2022 | 73.75 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 12.89 Mn |
| Sep 30, 2021 | 2.34 Mn |
BridgeBio Pharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();